Skip to content
MarketScale
‹ Back to IndustriesHealthcare

NIH Puts New Clinical Trial Guidelines Into Effect

Researchers requesting funding for clinical trials must determine if their research meets new criteria set by new NIH guidelines. The new guidelines breaks from the traditional understanding to also  include both basic biomedical research and basic social and behavioral research. The switch has caused somewhat of a controversy, with some researchers claiming that the guidelines…

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

Share

Get featured

Want to get featured in MarketScale Healthcare?

Create a free MarketScale workspace and get your company's expertise featured across our Healthcare coverage. No credit card, no demo required.

Request an invite

Researchers requesting funding for clinical trials must determine if their research meets new criteria set by new NIH guidelines. The new guidelines breaks from the traditional understanding to also include both basic biomedical research and basic social and behavioral research.

The switch has caused somewhat of a controversy, with some researchers claiming that the guidelines are too broad, and the new policies will increase researcher burdens. In September, more than 3500 scientists signed an open letter requesting NIH to delay the policy. Researchers conducting trials are now required to register and report results on ClinicalTrials.gov, but, if researchers impacted by the change do not select a funding opportunity that supports clinical trials when they apply to NIH, their grant is subjected to be rejected without a review.

Though some clarification from NIH in recent months has quelled many of the concerns expressed, some researchers have lingering doubts. “There’s still a problem, but the problem is less dire than the original set of concerns that we had,” says cognitive psychologist Jeremy Wolfe of the Harvard University.[1]

The guidelines go into effect on January 25th.

[1]

http://www.sciencemag.org/news/2018/01/nih-s-new-clinical-trial-policy-kicks-despite-concerns-basic-behavioral-researchers

Your experts belong here

Every story in MarketScale Healthcare starts with a company putting its clinicians, service-line leaders, and field engineers on the record. Buyers are already reading this topic. The only question is whose experts they find.

Service-line buyers vet vendors quietly, and your clinicians become the proof they find while doing it.

Get your team featuredSee how it works15 minutes, straight to a calendar.

Follow Healthcare Insights

Get new expert content in your inbox.

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. See how AI describes your company today, and where competitors show up instead.

Free workspace

You just read one Healthcare expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your clinicians, service-line leaders, and field engineers into the articles, video, and social content Healthcare buyers are searching for. Create a free workspace and see it with your own people. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale Studio workspace
One video edit a month, on us
AI writing, editing, and publishing tools
In-platform coaching to learn the system

More Healthcare Insights

Bobby Hilliard - Board Chair, HealthConnect Texas

Bobby Hilliard is the Board Chair of HealthConnect Texas, an organization operating in the healthcare sector. HealthConnect Texas focuses on improving healthcare connectivity and accessibility. The organization aims to streamline healthcare services and enhance patient outcomes.

  • 01HealthConnect Texas is focused on enhancing healthcare connectivity and accessibility.
  • 02The organization aims to improve healthcare service efficiency and patient outcomes.
  • 03Bobby Hilliard serves as the Board Chair of HealthConnect Texas.

Aug 20, 2026

Maureen Sanders - Vice Chair, HealthConnect Texas

Maureen Sanders serves as the Vice Chair at HealthConnect Texas, a prominent organization in the healthcare sector. The organization focuses on improving patient care and healthcare delivery.

  • 01HealthConnect Texas is dedicated to improving healthcare delivery.
  • 02Maureen Sanders holds the position of Vice Chair at HealthConnect Texas.

Aug 20, 2026

Ambient AI is moving from clinician productivity to consent and revenue-cycle controls

Ambient AI is moving from clinician productivity to consent and revenue-cycle controls

Ambient artificial intelligence (AI) in healthcare is rapidly advancing from enhancing clinician productivity to broader applications in consent and revenue-cycle control. Hospitals must now manage the use of ambient documentation tools, such as microphones and AI models, with the same scrutiny as other operational technologies. This evolution underscores the growing importance of governing AI technologies in clinical settings to ensure compliance and effectiveness.

  • 01Hospitals are increasingly using ambient AI for tasks beyond clinician productivity, including managing consent and revenue cycles.
  • 02The deployment of ambient documentation requires hospitals to regulate microphones and AI models as strictly as other technologies.
  • 03The expansion of ambient AI in healthcare signifies a shift towards comprehensive governance of AI tools.

Aug 20, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512